Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

08/07/18GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
08/03/18GBT Announces New Employment Inducement Grants
08/02/18GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results
07/03/18GBT Announces New Employment Inducement Grants

More »

Media Resources

Stay Informed

Sign up to receive email updates about ongoing sickle cell disease clinical studies, awareness and educational information and GBT news at:

Media Contact

Julie Normart